Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ChAdOx1 nCoV-19
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Agreement
Symbiosis, AstraZeneca Sign Supply Agreement for Sterile Vaccine Manufacture
Details : Under the agreement, Symbiosis will provide AstraZeneca fast-track access to sterile vaccine drug product manufacturing capacity for clinical trial supply.
Product Name : AZD1222
Product Type : Vaccine
Upfront Cash : Undisclosed
June 22, 2020
Lead Product(s) : ChAdOx1 nCoV-19
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Agreement